Compare Carlyle Group Inc (CG) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Carlyle Group Inc vs Nuwellis Inc — how do they compare? Carlyle Group Inc trades at $44.23 (market cap $16.37B), while Nuwellis Inc trades at $3.23 (market cap $1.17M). The key difference: Carlyle Group Inc is far larger — about 13991.5× Nuwellis Inc's market cap, and Carlyle Group Inc pays a 3.08% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| CG | NUWE | |
|---|---|---|
Market Cap | $16.37B | $1.17M |
Sector | Financials | Technology |
52-Week High | $69.35 | $558.26 |
52-Week Low | $40.52 | $2.80 |
Dividend Yield | 3.08% | — |
Enterprise Value | — | -$636.97K |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CG trades at $44.14, down 1.27% on the day, with a neutral technical signal and bearish moving averages. The company reported revenue of $3.21B and net income of $808.70M for 2025, with a P/E ratio of 30.24. Recent developments include the acquisition of a majority stake in MAI Capital Management and the upcoming Q2 2026 earnings release on August 5, 2026.
The outlook is mixed, with analyst consensus leaning bullish (53.84% Buy) and a price target of $58.57 implying significant upside. However, risks include volatile cash flows from operations, recent earnings misses, and a high valuation. The stock's performance hinges on successful execution of growth initiatives and improved earnings consistency.
NUWE trades at $2.80, down 7.89% in the last session, with a bearish technical outlook from moving averages. The company reported a net loss of $17.52 million in 2025 despite $8.27 million revenue, reflecting a negative net margin of 217.22%. Recent developments include a CEO transition to Mike McCormick, a $6 million public offering in June 2026, and expansion in pediatric care installations, indicating strategic growth efforts amid financial challenges.
The outlook remains high-risk due to persistent losses and negative ROE/ROA, though low P/E and P/B ratios suggest undervaluation. Analyst sentiment is split evenly between buy and hold. Key risks include cash burn from negative operating cash flow and execution hurdles in scaling commercial adoption. Upside depends on revenue acceleration and cost management under new leadership.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Carlyle Group Inc
The Carlyle Group is one of the world's largest alternative-asset managers, with $376.4 billion in total assets under management, including $259.6 billion in fee-earning AUM, at the end of June 2022. The company has three core business segments: private equity, which includes private equity, real estate, infrastructure and natural resources funds (accounting for 41% of fee-earning AUM and 65% of base management fees during 2021), global credit (45% and 24%) and investment solutions (14% and 11%). The firm primarily serves institutional investors and high-net-worth individuals. Carlyle operates through 29 offices across five continents, serving close to 2,700 active carry fund investors from 95 countries.
Read more on CG →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
